ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
155 hedge funds and large institutions have $1.08B invested in Intercept Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 64 increasing their positions, 38 reducing their positions, and 42 closing their positions.
Holders
155
Holders Change
-12
Holders Change %
-7.19%
% of All Funds
3.87%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
33
Increased
64
Reduced
38
Closed
42
Calls
$117M
Puts
$94.1M
Net Calls
+$23M
Net Calls Change
-$23.4M
Top Buyers
Top Sellers
| 1 |
CG
1
Carmignac Gestion
Paris,
France
|
$0 |
| 2 |
2
Ameriprise
Minneapolis,
Minnesota
|
$84.2M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$1.64M |
| 4 |
O
4
OrbiMed
New York
|
$22.4M |
| 5 |
5
Macquarie Group
Sydney, NSW 2000,
Australia
|
$290K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
201
Two Sigma Investments
New York
| – | – | – | – |
|
202
Hudson Bay Capital Management
Stamford,
Connecticut
| – | – | – | – |
|
|
WAM
203
Wolverine Asset Management
Chicago,
Illinois
| – | – | – | – |
|
|
GT
204
Glenmede Trust
Philadelphia,
Pennsylvania
| $0 | 11 | +11 | New |
|